To include your compound in the COVID-19 Resource Center, submit it here.

Inotek: Fighting radicals

Emerging Company Profile

Inotek: Fighting radicals

Free radicals, or reactive oxygen species, carry an unpaired electron and can damage DNA. While other companies have focused on ways to reduce levels of oxidants or free radicals to treat a range of diseases, Inotek Corp. believes that its focus on later stages in the cellular damage pathway mediated by these molecules will prove to be more successful.

"These mechanisms are generic, and are broadly represented in a large spectrum of diseases," said Andrew Salzman, president and CEO.

Read the full 826 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers